An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
Clinical trial NCT03669588 · COMPLETED
Trial details
- NCT number
- NCT03669588
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2020-04-06
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.